{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:03:31Z","timestamp":1772525011933,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018133","name":"VitreoRetinal Surgery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.oret.2025.09.014","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:23:36Z","timestamp":1760073816000},"page":"283-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Litigation Involving Intravitreal Injections in Ophthalmology"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0529-2845","authenticated-orcid":false,"given":"Maria A.","family":"Bantounou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3021-5630","authenticated-orcid":false,"given":"Matthew R.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.09.014_bib1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ajpath.2012.06.006","article-title":"A Brief history of anti-VEGF for the treatment of ocular angiogenesis","volume":"181","author":"Kim","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.oret.2025.09.014_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jamaophthalmol.2019.1971","article-title":"Analysis of anti-vascular endothelial growth factor injection claims data in US medicare part B beneficiaries from 2012 to 2015","volume":"137","author":"Berkowitz","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.014_bib3","article-title":"Significant investments will continue to advance retinal disease field","author":"Lindstrom","year":"2023","journal-title":"Healio"},{"key":"10.1016\/j.oret.2025.09.014_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/ICU.0000000000000850","article-title":"Complications of intravitreal injections: 2022","volume":"33","author":"Patel","year":"2022","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.014_bib5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamainternmed.2017.0311","article-title":"Rates and characteristics of paid malpractice claims among US physicians by specialty, 1992-2014","volume":"177","author":"Schaffer","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.oret.2025.09.014_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/25160435221139686","article-title":"Glaucoma-related malpractice litigation in the United States: a review of the WestLaw database","volume":"28","author":"Wong","year":"2023","journal-title":"J Patient Saf Risk Manag"},{"key":"10.1016\/j.oret.2025.09.014_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMsa1012370","article-title":"Malpractice risk according to physician specialty","volume":"365","author":"Jena","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oret.2025.09.014_bib8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3928\/23258160-20200501-04","article-title":"Malpractice litigation in vitreoretinal surgery and medical retina","volume":"51","author":"Engelhard","year":"2020","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2025.09.014_bib9","first-page":"687","article-title":"Medical malpractice claims resulting from retinal conditions and procedures: a 10-year review","volume":"55","author":"Laurenti","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.09.014_bib10","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1001\/jama.293.21.2609","article-title":"Defensive medicine among high-risk specialist physicians in a volatile malpractice environment","volume":"293","author":"Studdert","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.oret.2025.09.014_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ophtha.2019.07.013","article-title":"Surgical confusions in ophthalmology: description, analysis, and prevention of errors from 2006 through 2017","volume":"127","author":"Parikh","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.014_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcjo.2023.02.007","article-title":"Canadian legal cases in ophthalmology: a closer look at 40 years\u2019 worth of data","volume":"59","author":"Salimi","year":"2024","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.014_bib14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/eye.2011.89","article-title":"A review of safety incidents in England and Wales for vascular endothelial growth factor inhibitor medications","volume":"25","author":"Kelly","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2025.09.014_bib15","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.2147\/OPTH.S260226","article-title":"Malpractice litigation in ophthalmic trauma","volume":"14","author":"Engelhard","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.014_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000479559","article-title":"Malpractice litigation in ocular oncology","volume":"4","author":"Engelhard","year":"2018","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.oret.2025.09.014_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/09273948.2016.1202289","article-title":"Medical malpractice in uveitis: a review of clinical entities and outcomes","volume":"26","author":"Reddy","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.oret.2025.09.014_bib18","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1001\/jamaophthalmol.2016.3190","article-title":"Malpractice litigation in pediatric ophthalmology","volume":"134","author":"Engelhard","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.09.014_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ogla.2020.10.013","article-title":"Malpractice litigation in glaucoma","volume":"4","author":"Engelhard","year":"2021","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.oret.2025.09.014_bib20","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMsa054479","article-title":"Claims, errors, and compensation payments in medical malpractice litigation","volume":"354","author":"Studdert","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oret.2025.09.014_bib21","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ophtha.2020.10.013","article-title":"Medical malpractice lawsuits involving ophthalmology trainees","volume":"128","author":"Watane","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.014_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","article-title":"HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration","volume":"127","author":"Dugel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.014_bib24","series-title":"Update: brolucizumab\u2019s safety under review","author":"Rajan","year":"2020"},{"key":"10.1016\/j.oret.2025.09.014_bib27","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ophtha.2020.04.017","article-title":"Retinal vasculitis and intraocular inflammation after intravitreal injection of brolucizumab","volume":"127","author":"Baumal","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.09.014_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/2474126420930863","article-title":"Occlusive retinal vasculitis following intravitreal brolucizumab","volume":"4","author":"Witkin","year":"2020","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.oret.2025.09.014_bib29","article-title":"Retinal arterial occlusive vasculitis following intravitreal brolucizumab administration","volume":"18","author":"Haug","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.oret.2025.09.014_bib30","article-title":"Severe vision loss secondary to retinal arteriolar occlusions after multiple intravitreal brolucizumab administrations","volume":"18","author":"Jain","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.oret.2025.09.014_bib31","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1188\/18.ONF.E1-E13","article-title":"Impact of a barcode medication administration system on patient safety","volume":"45","author":"Macias","year":"2018","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.oret.2025.09.014_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.mayocpiqo.2018.09.001","article-title":"Implementation of bar-code medication administration to reduce patient harm","volume":"2","author":"Thompson","year":"2018","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.oret.2025.09.014_bib33","doi-asserted-by":"crossref","first-page":"E573","DOI":"10.36076\/ppj.2012\/15\/E573","article-title":"Assessment of infection control practices for interventional techniques: a best evidence synthesis of safe injection practices and use of single-dose medication vials","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.oret.2025.09.014_bib34","first-page":"501","article-title":"Invasive Staphylococcus aureus infections associated with pain injections and reuse of single-dose vials--Arizona and Delaware, 2012","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.oret.2025.09.014_bib35","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/SLA.0b013e3181d970e3","article-title":"Effect of a 19-item surgical safety checklist during urgent operations in a global patient population","volume":"251","author":"Weiser","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.oret.2025.09.014_bib36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/PTS.0000000000000188","article-title":"U.S. compounding pharmacy-related outbreaks, 2001\u20132013: public health and patient safety lessons learned","volume":"14","author":"Shehab","year":"2018","journal-title":"J Patient Saf"},{"key":"10.1016\/j.oret.2025.09.014_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/picr.PICR_147_16","article-title":"Informed consent process: a step further towards making it meaningful","volume":"8","author":"Kadam","year":"2017","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.oret.2025.09.014_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1740774520971770","article-title":"Details of risk\u2013benefit communication in informed consent documents for phase I\/II trials","volume":"18","author":"Kahrass","year":"2021","journal-title":"Clin Trials"},{"key":"10.1016\/j.oret.2025.09.014_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/2042098620909614","article-title":"Practical applications of regulatory requirements for signal detection and communications in pharmacovigilance","volume":"11","author":"Malikova","year":"2020","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.oret.2025.09.014_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13690-025-01512-8","article-title":"A global scoping review on the patterns of medical fraud and abuse: integrating data-driven detection, prevention, and legal responses","volume":"83","author":"Najar","year":"2025","journal-title":"Arch Public Health"},{"key":"10.1016\/j.oret.2025.09.014_bib41","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1001\/archinternmed.2012.1416","article-title":"Outcomes of medical malpractice litigation against US physicians","volume":"172","author":"Jena","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.oret.2025.09.014_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IOP.0000000000000025","article-title":"In the eyes of the law: malpractice litigation in oculoplastic surgery","volume":"30","author":"Svider","year":"2014","journal-title":"Ophthalmic Plast Reconstr Surg"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025004397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025004397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:23:39Z","timestamp":1772522619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025004397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2468653025004397"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.09.014","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Litigation Involving Intravitreal Injections in Ophthalmology","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}